ANIP - CIK 0001023024
ANI PHARMACEUTICALS INC (ANIP) reported net income of $78.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $78.00M | +510.5% |
| FY 2024 | -$19.00M | -200.0% |
| FY 2023 | $19.00M | +139.6% |
| FY 2022 | -$48.00M | -11.6% |
| FY 2021 | -$43.00M | -90.7% |
| FY 2020 | -$22.55M | -470.0% |
| FY 2019 | $6.09M | -60.7% |
| FY 2018 | $15.49M | +1540.0% |
| FY 2017 |
ANI PHARMACEUTICALS INC (ANIP) reported net income of $78.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, ANI PHARMACEUTICALS INC's net income grew from -$1.51M to $78.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$1.08M |
| -127.4% |
| FY 2016 | $3.93M | -74.4% |
| FY 2015 | $15.38M | -46.5% |
| FY 2014 | $28.75M | +9450.5% |
| FY 2013 | $301.00K | +120.0% |
| FY 2012 | -$1.51M | - |